cropped-cropped-favicon-270x270-1.png

MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world, particularly in the hematology domain. In collaboration with Belgian and international experts, we bring the newest data to Belgian physicians.

Now live

EHA 2025

30th EHA Congress, taking place in Milan from June 12–15, 2025

ICML 2025

ICML International Conference Malignant Lymphoma Lugano 17-21 June 2025

Coming up

Past congresses

ASCO 2025

American Society of Clinical Oncology (ASCO) 2025, from 30 May till 3 June 2025

EBMT 2025

European Society for Blood and Marrow Transplantation (EBMT) 2025, from March 30 to April 2

ASH San Diego 2024

American Society of Hematology (ASH ) 2024, from December 7 to 10

EHA Madrid 2024

The European Hematology Association (EHA), from June 13 to June 16

Latest publications

SEQUOIA – Results in Arm D

The SEQUOIA Arm D study explored the combination of zanubrutinib and venetoclax for untreated CLL/SLL patients, including those with abnormal TP53. Both normal and abnormal TP53 cohorts showed high response

See video »

Real-world outcomes of axi-cel

Dr Allison Winter presented at ICML 2025 data that highlight a collaboration between KITE and the CIBMTR data registry, examining the outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of

See video »

Phase 2 TRANSCEND FL study

At ICML 2025 in Lugano, new data from the phase 2 TRANSCEND study for lisocabtagene maraleucel (liso-cel) CAR-T cell therapy for indolent lymphoma were communicated.

See video »

SWOG S1826 TRIAL

At the ICML meeting, the results from the S1826 study were discussed, which focused on patients with advanced-stage Hodgkin Lymphoma (HL). This randomised phase 3 study compared brentuximab vedotin plus

See video »